Counting Down to Bio-IT World Expo 2010 

We are less than three months away from the kick off to the 2010 Bio-IT World Expo in Boston, being held from April 20-22). All signs point to a brilliant event, with registrations pouring in and exhibitors scrambling for the final few booths. We hope you'll consider joining us.

Our confirmed keynotes include Christoph Westphal, co-founder and CEO of Sirtris Pharmaceuticals and senior VP for external drug discovery at GlaxoSmithKline, which snapped up Sirtris for a cool $700 million last year. Sirtris attracted a wealth of media attention for its successful work in developing drugs called sirtuins, which act along the lines of resveratrol, the active ingredient in red wine. Westphal has an unparalleled view of the challenges and opportunities facing the pharma industry, and it will be great to hear how the former venture capitalist and entrepreneur is now trying to innovate pharma from within.

We'll also welcome John Halamka, CIO of Harvard Medical School, and an authority of electronic medical records, health informatics, and one of the first ten intrepid volunteers for George Church's Personal Genome Project. Halamka is one of the country's key figures in the ongoing healthcare debate, advising the government on technology solutions for modernizing health care records, not to mention the challenge of running the IT and data management tools for one of the country's largest and most prestigious medical schools.

We'll be announcing our third keynote very shortly, and think it will fit in superbly with the direction of the bio-IT field. Stay tuned!
The opening day, April 20, features a series of pre-conference workshops on topics including cloud computing, imaging informatics, text mining and next-generation sequencing. These are dynamic, information-rich sessions, not to mention fabulous networking opportunities.

Our main conference features seven tracks, from IT infrastructure to bioinformaitcs and next-gen data analysis, cheminformatics and molecular modeling to e-clinical research and e-health. Just a few of our confirmed speakers include Sandy Aronson (Partners Healthcare), Toby Bloom (Broad Institute), Phil Bourne (UCSD/PLoS Computational Biology), Ken Buetow (caBIG), Phil Butcher (Sanger Institute), Stephen Friend (Sage Bionetworks), William Hayes (Biogen-Idec), James Heywood (PatientsLikeMe), Craig Lipset (Pfizer), Pardis Sabeti (Harvard), John Oberington (EMBL-EBI), Eric Perakslis (J&J), and Mollie Shields-Uehling (SAFE-Biopharma).
There are plenty of other highlights as well, including the Benjamin Franklin Award for bioinformatics and the 2010 Best Practices Awards dinner on April 21, where some 200 guests will be the first to learn and hear from the winners of this year's competition. (There is still time to enter the competition!) And we're looking forward to the Best Of Show competition, always a competitive event to recognize the most outstanding new products on the exhibit hall floor.

Bio-IT World Expo debuted in 2002, and for those of us associated with the event in all that time, it is incredibly gratifying to see the event truly gaining momentum. Please join us for the show, or if you just want to pop in and hear 1-2 keynotes, apply for a complimentary exhibit hall/keynote pass. See you in April!

Kevin Davies
Editor, Bio-IT World 

Oxford Nanopore Raises $28 Million in New Funds
By Kevin Davies 

One of the most exciting companies developing third-generation DNA sequencing platforms, the UK's Oxford Nanopore Technologies, has raised a further $28 million in new funding. Read more. 

Running tranSMART for the Drug Development Marathon
By Kevin Davies 

If you sense a certain irresistible Lance Armstrong-like determination when meeting Centocor's Eric Perakslis, it is not a coincidence. Perakslis, the VP of R&D Informatics at Centocor R&D (and newly appointed member of the Corporate Office of Science and Technology at J&J) is a cancer survivor-he was diagnosed with stage III kidney cancer at 38-and has run marathons in support of Armstrong's LiveStrong Foundation. Read more. 

Life Technologies SOLiD 4 System Sights $6000 Genome
By Kevin Davies 

Life Technologies has introduced the latest version of its next-generation sequencing system, the Applied Biosystems SOLiD 4, with a throughput of 100 Gigabases and a reagent cost of $6,000 per human genome. Read more. 

Last Week's Most-Read Story
Illumina's HiSeq 2000: Secrets and Buys 

Bio-IT Briefs
January 26 | Full Stories 

• Health Decisions president publishes agile trial book 
• GATC Biotech purchases new Illumina platform 
• Genedata and Bayer Schering Pharma AG announce multi-year collaboration 

WEBINAR
Next-Generation Clinical Trial and Data Management Applications 
Sponsored by Adobe

This webinar introduces i3Cube - a web-based, fully integrated, clinical trial and data management system built on Adobe's LiveCycle® Enterprise Suite.  I3 cube provides end-to-end automation that delivers unprecedented visibility into information that sponsors need to accelerate the study process and complete trials efficiently. Viewers will learn more about: 

• Creating faster and more efficient trial processes 
• Reducing investigator burden 
• Real-time sponsor transparency into study information 
• Enterprise solutions based on Adobe LiveCycle® ES utilizing cross-platform clients of Reader, Flash and AIR 

Download now. 

To have your podcast featured here, contact Lynn Cloonan for more information. 

SPONSORED LINKS 

• Simplify Data Management-Free Technical Brief 
• Next-Gen Clinical Trial and Data Management Apps: Free Webinar 
• Reducing bottlenecks in GxP labs with electronic SOP system 
• Computational informatics software solution 
• Increase Research IT Productivity. Reduce R & D Support Costs. Free Whitepaper. 
• Streamline Clinical Research---Free Whitepaper 
• Merge, organize, analyze and visual chemical and biological data 
• The Future of Data and IT-View This Panel Discussion 
• Improve Study Start-Up Time: Complimentary Whitepaper 
• Transparent Data Migration Explored-Free Whitepaper 
• Translational Medicine :---Complimentary Podcast! 
• Electronic Notebook: Capture and re-use data; enhance collaboration; streamline experimental IP! 
• Overcome key challenges in site selection, recruitment, and data collection 
• Drug Development, Clinical Trial Strategies, Drug Safety 

Insight Pharma Reports

Multiplex Assays: Evolving Technologies, Applications, & Future Directions 
Author: Ken Rubenstein, Ph.D. 

Multiplex Assays has generated a great deal of excitement in the past 15 years.  This report examines the role of multiplex and multi-analyte biomarker assays in translational medicine.  Read more . 

FEATURED EVENTS 

• Molecular Med Tri-Conference Short Courses 
• Tufts Postgraduate Course in Clinical Pharmacology, Drug Development and Regulation | Feb 8-12, 2010 | Boston 
• Electronic Data in Clinical Trials, March 8-9, 2010, Philadelphia 
• eCTD 2010 - One Day Forum, March 10, 2010, Philadelphia 
• Summit for Clinical Ops Executives (SCOPE) - March 8-11, 2010 | Philadelphia 
• Drug Development Latin America, March 10-11, 2010, Philadelphia 
• Bio-IT World Conference & Expo • April 20-22, 2010, World Trade Center •Boston, MA 
• Bio-IT World Web Symposia Series 
• Barnett Educational Services 
• Cambridge Healthtech Events 
  

  To have your event featured here, contact Lynn Cloonan for more information.